Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in Diabetologia

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    February 2016
  1. ZETHELIUS B, Gudbjornsdottir S, Eliasson B, Eeg-Olofsson K, et al
    Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter].
    Diabetologia. 2016.
    PubMed     Text format    


  2. HERMIDA RC, Ayala DE, Mojon A, Fernandez JR, et al
    Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention.
    Diabetologia. 2016;59:244-54.
    PubMed     Text format     Abstract available


    January 2016
  3. LI Y, Gao X, Winkelman JW, Cespedes EM, et al
    Association between sleeping difficulty and type 2 diabetes in women.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    December 2015
  4. MONTAIGNE D, Coisne A, Sosner P, Lacroix D, et al
    Electrical atrial vulnerability and renal complications in type 2 diabetes.
    Diabetologia. 2015.
    PubMed     Text format    


  5. HERMIDA RC, Ayala DE, Mojon A, Fernandez JR, et al
    Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention.
    Diabetologia. 2015.
    PubMed     Text format    


  6. RUTTER MK
    Night-time blood pressure: a role in the prediction and prevention of diabetes?
    Diabetologia. 2015.
    PubMed     Text format     Abstract available


    November 2015
  7. HERMIDA RC, Ayala DE, Mojon A, Fernandez JR, et al
    Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2015.
    PubMed     Text format    


    October 2015
  8. BENEDICT C
    Antihypertensive medication prior to nocturnal sleep reduces the risk of new-onset type 2 diabetes in hypertensive patients: a role for slow-wave sleep?
    Diabetologia. 2015.
    PubMed     Text format    


    September 2015
  9. LAMBERS HEERSPINK HJ, Johnsson E, Gause-Nilsson I, Sjostrom C, et al
    Erratum to: Abstracts of the 51st Annual Meeting of the EASD, Stockholm 2015. 'Dapagliflozin reduces albuminuria on top of renin-angiotensin system blockade in hypertensive patients with diabetes'.
    Diabetologia. 2015.
    PubMed     Text format    


  10. HERMIDA RC, Ayala DE, Mojon A, Fernandez JR, et al
    Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2015.
    PubMed     Text format     Abstract available


    June 2015
  11. ZETHELIUS B, Gudbjornsdottir S, Eliasson B, Eeg-Olofsson K, et al
    Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).
    Diabetologia. 2015.
    PubMed     Text format     Abstract available


  12. CARDOSO CR, Moran CB, Marinho FS, Ferreira MT, et al
    Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Diabetologia. 2015.
    PubMed     Text format     Abstract available


    March 2015
  13. CEFALU WT, Stenlof K, Leiter LA, Wilding JP, et al
    Effects of canagliflozin on body weight and relationship to HbA and blood pressure changes in patients with type 2 diabetes.
    Diabetologia. 2015.
    PubMed     Text format     Abstract available


  14. AFGHAHI H, Svensson MK, Pirouzifard M, Eliasson B, et al
    Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register.
    Diabetologia. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: